Denosumab STANDs to give patients FREEDOM to DECIDE

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours

By Gibiansky Leonid

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 247-260

Adis International

Access to resources Recommend Favorite

Denosumab: In the Prevention of Skeletal-Related Events in Patients with Bone Metastases from Solid Tumours

By Scott Lesley J. Muir Victoria J.

Drugs, Vol. 71, Iss. 8, 2011-05 ,pp. : 1059-1069

Adis International

Access to resources Recommend Favorite

Denosumab delivers in postmenopausal osteoporosis

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Denosumab's value deduced at ISPOR

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Not to decide is to decide: ignoring susceptibility is not `good science'

By Finkel A.M.

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 219-227

Elsevier

Access to resources Recommend Favorite